Healthtech Startups

Zentake offers a drag-and-drop patient intake form builder designed for healthcare practices to automate paperwork and patient check-in workflows. The platform includes features for form creation, e-signature capture, integrations with EHR systems, and HIPAA compliance.

1 investor

Zentox manufactures air purification units that use proprietary Photocatalytic Oxidation technology to remove viruses, allergens, bacteria, mold, and VOCs from indoor air. The company serves residential, commercial, and institutional customers including hospitals, offices, schools, and homes.

1 investor

Zenyum is a consumer dental brand offering oral care and "Smile Cosmetics" products, including invisible braces/aligners, sonic toothbrushes, whitening strips, toothpaste, and flossing products. It sells direct to consumers and works with partner dentists across nine markets in Asia.

1 investor

ZeOmega provides healthcare enterprise management software for health plans and other risk-bearing organizations, offering integrated care management, prior authorization, and workflow solutions. The company serves payers and healthcare administrators with clinical content, integration capabilities, and rules-engine technology.

1 investor

Zeph develops a digital health platform with clinical-grade sensors to help patients manage respiratory conditions like COPD through home-based rehabilitation and evidence-based exercises. The platform serves patients, clinicians, and care teams seeking better respiratory health management.

1 investor

Zepto develops a targeted liquid biopsy platform for infectious disease diagnostics, offering plasma-based molecular testing through its CLIA reference laboratory and an integrated sample-to-result platform for use in hospital laboratories. It also provides analytical performance and reference testing support to help diagnostics obtain FDA clearance.

1 investor

Zergo produces a urine-based test designed to assist women with fertility and conception.

1 investor

Zerion is a pharmaceutical development company that uses its Dispersome formulation technology to improve the solubility and therapeutic performance of poorly soluble drugs. Spun out of the University of Copenhagen in 2019, it builds an internal drug pipeline while partnering with pharmaceutical companies to solve drug solubility challenges.

1 investor

Zest Dental Solutions designs, manufactures, and distributes dental care solutions including implant anchors, restorative materials, and diagnostic equipment. The company serves dental practitioners and patients across the full spectrum of dental care, from natural tooth preservation to complete tooth replacement.

1 investor

Zetagen is a biotechnology company focused on bone-related disease, developing small-molecule therapeutics and approaches targeting bone tumor progression, stem cell activity to promote bone formation, and cancers such as Ewing's sarcoma.

1 investor

ZetrOZ Systems develops wearable, non-invasive bioelectronic ultrasound devices that deliver sustained acoustic medicine (sam®) to treat acute and chronic musculoskeletal conditions, supporting tissue recovery and pain relief. The company serves the sports medicine and healthcare market and manufactures its sam® product line in the United States.

1 investor

1 investor

Zeus develops sleep improvement devices, including anti-snoring and obstructive sleep apnea management products, based on proprietary TESLA technology developed through collaboration with medical institutions and researchers.

1 investor

ZEV Biotech develops IRIS®, an integrated molecular diagnostics platform combining reagents, hardware, and software that can test multiple genomic biomarkers across small batches of patient samples. It targets laboratories, research institutions, and hospitals, aiming to make molecular diagnostics accessible in decentralized settings, with a focus on Latin America.

1 investor

Zevra Therapeutics develops and commercializes rare disease treatments, including therapies for Niemann-Pick disease type C and urea cycle disorders. The company serves patients with inherited metabolic and genetic disorders through FDA-approved pharmaceutical products.

1 investor

Shanghai Zhenge Biotech is an independent CDMO company providing contract development and manufacturing services for biopharmaceutical clients during clinical development and commercialization phases. The company offers a comprehensive range of services including drug development, cell line construction, process development, analytical methods, raw material production, drug formulation, stability studies, and animal cell culture media development.

1 investor

Zhaoyang operates an internet hospital platform focused on mental and psychiatric care, connecting psychiatrists and therapists with patients for online consultations, follow-ups, patient management, and prescriptions. It serves patients seeking remote mental health treatment and provides doctors with an online private clinic, with a nationwide focus in China.

1 investor

A personal care and household products company that develops daily-use items including tissue, mother-and-baby products, and other household goods formulated with plant-derived ingredients for health-conscious Chinese families.

1 investor

Zhongze Therapeutics is a drug discovery company developing innovative agents for psychiatric disorders, with a pipeline targeting unmet clinical needs in schizophrenia, depression, bipolar disorder, and autism through multi-target, multi-mechanism approaches. It focuses on the research, development, and commercialization of novel treatments in the central nervous system and psychiatric therapeutics space.

1 investor

ZIBRIO develops a balance assessment technology using machine learning to measure postural stability through a one-minute standing test, designed for both self-administration and clinical settings to identify fall risk in older adults. The company serves healthcare providers and older adults seeking fall prevention and balance monitoring.

1 investor

Zidan Medical develops an endobronchial radiofrequency ablation system, using a small flexible RF catheter with "virtual electrode" forward-throw technology to deliver targeted, temperature-controlled energy to destroy lung lesions. The device is intended for treating lung cancer patients.

1 investor

Ziehm Imaging develops mobile medical imaging systems, such as C-arm imaging technology, used in healthcare facilities worldwide. It provides the imaging hardware along with clinical and technical support for healthcare providers.

1 investor

Zilia develops a medical imaging platform that measures biomarkers in the eye to enable early detection of preventable blindness, including glaucoma and diabetic retinopathy. The company leverages spectroscopy and artificial intelligence to provide non-invasive assessment of ocular metabolic activity.

1 investor

Zingage provides coordination infrastructure for home healthcare agencies to automate scheduling, handle real-time call-outs and emergencies, and improve care delivery for families. The platform serves home care agencies, caregivers, and families seeking reliable in-home care coordination.

1 investor